feetsee.us

What It Is

Feetsee is a home-based medical device and software combination for diabetic foot risk management. It uses non-contact thermal imaging and optical cameras to collect foot data, then applies algorithms to identify early signs such as inflammation. The goal is to help patients, caregivers, and healthcare providers detect the risk of diabetic foot ulcers earlier. Its setup includes a hardware stand/camera system, a patient mobile App, provider-side software, and a carrying case.

Core Capabilities and Product Experience

Based on the website information, Feetsee’s core value proposition is “non-contact, at-home, daily, and automatically recorded.” The device does not require patients to stand on a sensing surface, which can reduce additional pressure on the feet and lower the risk of contact-based contamination. The system claims to capture 19,200 thermal imaging points across the entire foot and combine them with optical images and algorithmic analysis. Patients can view a foot-check timeline in the iOS/Android App, while notifications are sent to both patients and healthcare providers when abnormalities are detected. For people with limited vision, mobility, or caregiving resources, this at-home daily screening approach has practical value.

Pricing, Security, and Integrations

The website does not disclose the device price, subscription fees, per-patient pricing, or clinic licensing model, nor does it mention a free trial. In terms of security, Feetsee explicitly states that its software is HIPAA-compliant and supports secure clinician access and data sharing, but it provides limited detail on encryption, audit logs, data residency, and related controls. From an enterprise software perspective, only the patient-side and provider-side components are currently visible; there is no clear information about EHR/EMR integration, open APIs, developer documentation, team permissions, or organization-level administration.

Pros, Cons, and Best Fit

Its strengths are a highly focused use case, a testing method that is relatively friendly to high-risk foot patients, and a workflow in which mobile feedback and physician notifications can form a closed loop for early screening. The drawbacks are the lack of commercialization details, as well as insufficient information on medical device certification scope, after-sales support, clinical applicability boundaries, and system integration capabilities. It is best suited for high-risk diabetic foot patients, family caregivers, podiatry clinics, endocrinology clinics, and remote patient monitoring programs evaluating such solutions.

Access in China and Alternatives

The website does not explain availability, purchasing, payment, after-sales support, or compliance implementation in mainland China, so these remain unknown. For use in China, key issues to confirm include device import/registration qualifications, cross-border data handling, and the usability of the clinician-side software. Alternative directions include local chronic disease management platforms, internet hospital follow-up systems, hospital-based diabetic foot specialty follow-up programs, and other foot temperature monitoring or remote patient monitoring devices.